Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries

Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries

Purpose To compare the short-term cost and effectiveness of calcipotriol/betamethasone dipropionate (Cal/BD) cutaneous foam against nonbiologic systemics in psoriasis patients for whom oral systemic or topical therapy is considered appropriate in seven European countries. Methods Matching-adjusted i...

Full description

Bibliographic Details
Main Authors: Deepak M. W. Balak, Jose-Manuel Carrascosa, Stamatis Gregoriou, Piergiacomo Calzavara-Pinton, Anthony Bewley, Joana Antunes, Martin E. Nyeland, Marta G. Viola, Laura M. Sawyer, Lidia Becla
Format: Article
Language:English
Published: Taylor & Francis Group 2021-10-01
Series:Journal of Dermatological Treatment
Subjects:
psoriasis
calcipotriol/betamethasone dipropionate cutaneous foam
topical therapy
systemic therapy
cost per response
Online Access:http://dx.doi.org/10.1080/09546634.2019.1707754

Internet

http://dx.doi.org/10.1080/09546634.2019.1707754

Similar Items